Pfizer Ltd
PFIZERPfizer Ltd
PFIZER
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 35.45 | 5.78 | 0.99% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.58 | 5.12 | 0.70% |
Forecast & Ratings
Detailed Forecastfrom 5 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Pfizer Limited is a pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,008.59 | 2,109.22 | 2,197.85 | 2,082.80 | 2,248.89 | 2,335.67 | 2,319.67 | 2,673.64 | 2,558.81 | 2,429.28 | ||||||||||
Raw Materials | 822.22 | 735.20 | 812.24 | 712.17 | 838.78 | 829.02 | 783.39 | 1,020.93 | 817.19 | 1,641.91 | ||||||||||
| Power & Fuel Cost | 10.40 | 10.43 | 10.34 | 12.34 | 11.45 | 11.04 | 5.79 | 5.67 | 6.51 | |||||||||||
| Employee Cost | 236.36 | 277.34 | 303.89 | 314.29 | 323.84 | 364.51 | 361.06 | 403.67 | 331.68 | |||||||||||
| Selling & Administrative Expenses | 359.92 | 375.97 | 383.12 | 316.73 | 335.32 | 319.66 | 268.67 | 310.77 | 298.03 | |||||||||||
| Operating & Other expenses | 121.17 | 180.53 | 106.54 | 112.34 | 6.48 | 54.70 | 107.24 | 34.01 | 162.40 | |||||||||||
EBITDA | 458.52 | 529.75 | 581.72 | 614.93 | 733.02 | 756.74 | 793.52 | 898.59 | 943.00 | 787.37 | ||||||||||
| Depreciation/Amortization | 249.52 | 57.93 | 62.93 | 66.25 | 71.39 | 103.24 | 109.41 | 115.00 | 105.51 | 83.73 | ||||||||||
| PBIT | 209.00 | 471.82 | 518.79 | 548.68 | 661.63 | 653.50 | 684.11 | 783.59 | 837.49 | 703.64 | ||||||||||
| Interest & Other Items | 1.51 | 1.40 | 1.96 | 0.77 | 1.72 | 11.01 | 15.39 | 10.70 | 13.48 | 11.97 | ||||||||||
| PBT | 207.49 | 470.42 | 516.83 | 547.91 | 659.91 | 642.49 | 668.72 | 772.89 | 824.01 | 691.67 | ||||||||||
| Taxes & Other Items | 137.68 | 165.44 | 180.05 | 187.84 | 230.86 | 133.36 | 171.11 | 160.33 | 200.08 | 168.87 | ||||||||||
| Net Income | 69.81 | 304.98 | 336.78 | 360.07 | 429.05 | 509.13 | 497.61 | 612.56 | 623.93 | 522.80 | ||||||||||
| EPS | 18.47 | 66.66 | 73.61 | 78.70 | 93.78 | 111.28 | 108.76 | 133.88 | 136.37 | 114.27 | ||||||||||
| DPS | 12.50 | 15.00 | 20.00 | 20.00 | 22.50 | 330.00 | 35.00 | 35.00 | 40.00 | 40.00 | ||||||||||
| Payout ratio | 0.68 | 0.23 | 0.27 | 0.25 | 0.24 | 2.97 | 0.32 | 0.26 | 0.29 | 0.35 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Pfizer Ltd | 29.70 | 5.78 | 0.99% |
| Sun Pharmaceutical Industries Ltd | 34.86 | 4.98 | 0.93% |
| Cipla Ltd | 35.05 | 4.14 | 0.70% |
| Dr Reddy's Laboratories Ltd | 21.26 | 4.12 | 0.70% |
Price Comparison
Compare PFIZER with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 1.23%
Top 5 Mutual Funds holding Pfizer Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Nippon India SMALL CAP FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.9877% | Percentage of the fund’s portfolio invested in the stock 1.00% | Change in the portfolio weight of the stock over the last 3 months 0.40% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 111/214 (+10) |
Nippon India Multi Cap Fund - Growth Option - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.7609% | Percentage of the fund’s portfolio invested in the stock 0.68% | Change in the portfolio weight of the stock over the last 3 months -0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 69/110 (-5) |
Aditya Birla Sun Life ELSS Tax Relief '96 - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.7022% | Percentage of the fund’s portfolio invested in the stock 0.97% | Change in the portfolio weight of the stock over the last 3 months -0.54% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 37/64 (-19) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Trend In Dividends
PFIZER has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Current dividend yield is 0.98%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹9.75 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 11, 2023
Dividend/Share
₹35.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateAug 11, 2023
Dividend/Share
₹5.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Dividend/Share
₹30.00
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateAug 18, 2022
Dividend/Share
₹35.00
Ex DateEx Date
Aug 18, 2022
Cash Dividend
Ex DateEx DateAug 11, 2021
Dividend/Share
₹5.00
Ex DateEx Date
Aug 11, 2021
News & Opinions
Apple’s Tim Cook, BlackRock’s Fink among CEOs attending Xi Jinping dinner
2 weeks ago•Moneycontrol
Pfizer may open lower as Q2 revenue, profit take a hit
1 month ago•Moneycontrol
1 Stock to Buy, 1 Stock to Sell This Week: Lululemon, Pfizer
1 month ago•Investing.com
‘Monitor Side Effects of Antacid Esomeprazole’: Pharma Body Issues Alert for Doctors, Patients - News18
2 months ago•News18
Katalin Kariko, Drew Weissman awarded 2023 Nobel Prize in Medicine for mRNA COVID vaccines
2 months ago•Business Today
Pfizer Nears Pre-Pandemic Levels: Is the Stock Ready to Bottom Out?
2 months ago•Investing.com
Pfizer - Expect A Fresh Wave Of New Launches: Systematix Initiates Coverage With A ‘Buy’
3 months ago•Bloomberg Quint
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 4.2%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 1.03% to 0.8%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 11.62%, vs industry avg of 9.82%